Free Trial

520,000 Shares in CompoSecure, Inc. (NASDAQ:CMPO) Purchased by Guardian Point Capital LP

CompoSecure logo with Business Services background

Guardian Point Capital LP acquired a new position in CompoSecure, Inc. (NASDAQ:CMPO - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 520,000 shares of the company's stock, valued at approximately $7,972,000. CompoSecure comprises about 4.2% of Guardian Point Capital LP's portfolio, making the stock its 5th biggest position. Guardian Point Capital LP owned about 0.59% of CompoSecure as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CMPO. KLP Kapitalforvaltning AS purchased a new position in CompoSecure during the fourth quarter valued at approximately $75,000. Wolverine Asset Management LLC boosted its stake in CompoSecure by 76.3% during the fourth quarter. Wolverine Asset Management LLC now owns 9,335 shares of the company's stock valued at $143,000 after buying an additional 4,039 shares during the period. Price T Rowe Associates Inc. MD purchased a new position in CompoSecure during the fourth quarter worth about $156,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in CompoSecure by 33.3% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 10,201 shares of the company's stock worth $161,000 after acquiring an additional 2,547 shares during the last quarter. Finally, Clear Harbor Asset Management LLC purchased a new stake in shares of CompoSecure in the 4th quarter valued at about $162,000. Institutional investors own 37.56% of the company's stock.

CompoSecure Price Performance

CompoSecure stock traded up $0.44 during trading hours on Tuesday, reaching $12.33. The stock had a trading volume of 134,372 shares, compared to its average volume of 827,961. The company has a fifty day simple moving average of $10.88 and a 200-day simple moving average of $13.78. CompoSecure, Inc. has a 52 week low of $5.98 and a 52 week high of $17.71. The stock has a market cap of $1.26 billion, a PE ratio of -28.14, a PEG ratio of 2.63 and a beta of 0.87.

CompoSecure (NASDAQ:CMPO - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.06. The company had revenue of $103.90 million for the quarter, compared to analysts' expectations of $103.22 million. CompoSecure had a negative return on equity of 14.87% and a negative net margin of 5.63%. Research analysts predict that CompoSecure, Inc. will post 1.02 earnings per share for the current fiscal year.

Insider Buying and Selling at CompoSecure

In other CompoSecure news, insider Adam Joseph Lowe sold 5,000 shares of the firm's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $11.01, for a total value of $55,050.00. Following the completion of the sale, the insider now directly owns 1,481,036 shares in the company, valued at $16,306,206.36. This trade represents a 0.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CRO Amanda Mandy Gourbault sold 9,622 shares of the company's stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $16.09, for a total value of $154,817.98. Following the transaction, the executive now owns 821,782 shares in the company, valued at $13,222,472.38. This trade represents a 1.16% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have purchased 704,421 shares of company stock valued at $10,929,922 and have sold 34,340 shares valued at $430,701. Insiders own 74.99% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on CMPO shares. JPMorgan Chase & Co. decreased their price objective on shares of CompoSecure from $16.00 to $15.00 and set a "neutral" rating on the stock in a research report on Thursday, March 6th. Lake Street Capital dropped their price objective on shares of CompoSecure from $18.00 to $15.00 and set a "buy" rating for the company in a report on Thursday, March 6th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $15.00 target price on shares of CompoSecure in a research note on Tuesday. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $16.19.

View Our Latest Analysis on CompoSecure

CompoSecure Profile

(Free Report)

CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.

Read More

Institutional Ownership by Quarter for CompoSecure (NASDAQ:CMPO)

Should You Invest $1,000 in CompoSecure Right Now?

Before you consider CompoSecure, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CompoSecure wasn't on the list.

While CompoSecure currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines